Bayer’s regorafenib gains orphan status for GIST
February 4, 2011Research and Development, Sales and Marketing Bayer, FDA, GIST, gastrointestinal stromal tumours, orphan drug, regorafenib
Bayer’s investigational compound regorafenib has been granted orphan drug status for the treatment of patients with gastrointestinal stromal tumours (GIST) …
Sparkling celebrations at PM Awards’ silver jubilee
February 4, 2011Medical Communications Langland, PM Society Advertising Awards, advertising, awards, pm society
The PM Society marked the 25th anniversary of its annual advertising awards with a ceremony that glittered almost as much …
Bayer and Zydus Cadila sign India deal
February 4, 2011Sales and Marketing Bayer, India, Indian pharmaceutical industry, Zydus Cadila
Bayer HealthCare and the Indian company Zydus Cadila have signed a deal to form a new joint venture. A new …
ABPI backs UK science after Pfizer’s R&D exit
February 4, 2011Research and Development Kent, Pfizer, Sandwich
The ABPI has defended the UK’s research environment against mounting criticism following Pfizer’s decision to close its Kent research base. …
LEC appoints joint creative directors
February 4, 2011Medical Communications Harry Armfield, Kim Hughes, LEC, Lane Earl Cox, appointment, medical communications
Lane Earl Cox has promoted Harry Armfield and Kim Hughes to the position of joint creative directors. Harry and Kim …
Working Life: Merck Sharp & Dohme medical director Paul Robinson
February 4, 2011Business Services, Research and Development MSD, Paul Robinson, Working Life, careers, merck sharp and dohme, recruitment
Paul Robinson, medical director at Merck Sharp & Dohme, looks at how his field is changing, the most enjoyable things …
Pressure mounts on Servier over Mediator controversy
February 3, 2011Sales and Marketing France, G5, Mediator, Servier, benfluorex
Dr Jacques Servier has stepped down from his role as head of a French pharma industry association as controversy grows …
Five capabilities of centered leadership
February 3, 2011Manufacturing and Production, Research and Development, Sales and Marketing Caroline Webb, Joanna Barsh, Josephine Mogelof, McKinsey & Company, leadership
The business environment has become more demanding: the global financial crisis and subsequent economic downturn have ratcheted up the pressure …
Pfizer appoints Dr Yvonne Greenstreet to specialty care business
February 3, 2011Research and Development Dr Yvonne Greenstreet, Pfizer, appointment, specialty care
Dr Yvonne Greenstreet has joined Pfizer to head up medicines development for its Specialty Care business unit. She moves to …
Roche weathers tough year and looks to pipeline for 2011
February 3, 2011Research and Development, Sales and Marketing 2010 pharma results, BRAF protein, GDC-0449, RG3616, RG7204, Roche, avastin, pertuzumab
Roche is looking to its innovative late-stage pipeline to help it get back on track for the next financial year …
Blood clot fears halt cancer trial enrolment
February 3, 2011Research and Development BMS, Bristol-Myers Squibb, Eli Lilly, NSCLC, lilly, necitumumab, non small cell lung cancer, non-small cell lung cancer
Lilly and BMS have stopped enrolment in a phase III trial of necitumumab, a new treatment for non-small cell lung …
Jango to manage Grünenthal pain awards
February 3, 2011Medical Communications Grunenthal, Jango, awards, disease awareness campaigns
Jango Communications has been appointed by Grünenthal to manage the Pain Awards Programme they are sponsoring this year. German-based Grünenthal, …
The Project Management Office – Accelerating Project Management Maturity
February 3, 2011Sales and Marketing Kinapse, White paper
Success in the life sciences industry depends on allocation of scarce resource to the right projects at different stages of …
Diabetes success for Sanofi, disappointment for Roche
February 2, 2011Roche, Sanofi, diabetes
The contrasting fortunes of two new diabetes became clear today, with Sanofi-Aventis lixisenatide performing well, as Roche abandoned taspoglutide.Sanofi’s lixisenatide, …
Government seeks to salvage Pfizer site
February 2, 2011Research and Development Pfizer, Sandwich
Science minister David Willetts says the government will do all it can to maintain pharma research in Kent, after Pfizer …
Leading universities sound alarm over UK research
February 2, 2011Research and Development Jobs, Pfizer, Sandwich, universities
Cuts to government funding for research in universities have been condemned by the UK’s top centres of learning. The government …
Cherry Wood new HCA chair
February 1, 2011Medical Communications Cherry Wood, HCA
The Healthcare Communications Association (HCA) has announced that Cherry Wood, managing director of Liberation Communications, has been elected its new …
Pfizer to close UK R&D site
February 1, 2011Research and Development Kent, Pfizer, R&D, Sandwich, closure
Pfizer has announced that it is to close its UK research site at Sandwich in Kent, with the loss of …
GSK settles Avandia case out of court
February 1, 2011Sales and Marketing Avandia, GSK, diabetes
GlaxoSmithKline this week settled a US federal lawsuit regarding its diabetes drug Avandia before it went to court. The company …
FDA process validation guidelines emphasise risk management
February 1, 2011Manufacturing and Production FDA, ICH, process validation
The FDA has published the final version of its Guideline on Process Validation, more than two years after the first …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
